UK Research and Innovation (UKRI) has announced the latest round of its prestigious Future Leaders Fellowships (FLF), awarding £120 million to 77 promising early-career researchers across the UK. These fellowships aim to empower the next generation of research and innovation leaders by providing them with the resources and support to lead cutting-edge projects. Among the wide-ranging initiatives funded are research into the causes of Alzheimer’s disease and lung cancer, underscoring the programme’s focus on tackling some of the most pressing health challenges of our time.
The FLF scheme is designed to provide long-term support—up to seven years—for researchers and innovators at a critical stage in their careers. This allows recipients to pursue ambitious, multidisciplinary work, and to explore emerging fields of research and innovation. Fellows are placed in the most suitable environments for their projects, whether that be universities, businesses, charities, or independent research organisations. This approach also helps facilitate collaboration across sectors and enhances mobility between academia and industry.
Out of the 77 funded projects, 13 are led by businesses and supported by Innovate UK, further highlighting the fellowship’s role in strengthening ties between research and industry. Fellows also gain access to the FLF Development Network, which offers leadership training, mentorship, networking opportunities, and seed funding for collaborative work—ensuring they are not only supported financially but also professionally.
Examples of successful projects include the development of a social media observatory at Royal Holloway University of London to study political content moderation; research at Cardiff University into how inflammation in the immune system may contribute to Alzheimer’s disease; and advanced manufacturing research at the University of Sheffield aimed at improving global supply chain data sharing and reducing carbon emissions. At University College London, a new lab is examining early biological changes related to lung cancer, with the aim of developing preventive treatments.
Frances Burstow, Director of Talent and Skills at UKRI, emphasised that the FLF programme supports researchers working across disciplines and sectors to bridge the gap between discovery and impact. UKRI Chief Executive, Professor Sir Ian Chapman, added that the fellowships are designed to help researchers turn bold ideas into innovations that benefit society and improve lives both in the UK and globally.